National Centre for Pharmacoeconomics

National Centre for

NCPE Ireland

Nalmefene (Selincro®)

Nalmefene (Selincro®) is indicated for the reduction of alcohol consumption in those aged ≥18 years with alcohol dependence, who do not require immediate detoxification.

Rapid Review

Commenced Completed Outcome
07/06/2013 28/06/2013 Full Pharmacoeconomic Evaluation Recommended

 Pharmacoeconomic Evaluation

Commenced Completed Outcome
21/10/2013  08/04/2014 Reimbursement recommended

The NCPE consider this to be a cost effective product for the defined patient population in combination with psychosocial intervention.